COVID-19 current figures
Latest COVID-19 clinical news updates
Lancet study estimates impact of physical distancing
A new modelling study conducted in a simulated Singapore setting has estimated that a combined approach of physical distancing interventions, comprising quarantine (for infected individuals and their families), school closure, and workplace distancing, is most effective at reducing the number of SARS-CoV-2 cases compared with other intervention scenarios included in the study.
While less effective than the combined approach, quarantine plus workplace measures presented the next best option for reducing SARS-CoV-2 cases, followed by quarantine plus school closure, and then quarantine only. All intervention scenarios were more effective at reducing cases than no intervention.
The study, published in The Lancet Infectious Diseases journal, is the first of its kind to investigate using these options for early intervention in Singapore using simulation. Despite heightened surveillance and isolation of individuals suspected to have COVID-19 and confirmed cases, the risk is ongoing, with the number of cases continuing to increase in Singapore.
Experts demand rejection of COVID-19 policy based on age
Experts are urging the Government to reject the formulation and implementation of policy to fight the Coronavirus (COVID-19) pandemic based solely on the age of the population.
The British Society of Gerontology has objected to any policy which differentiates the population by application of an arbitrary chronological age in restricting people’s rights and freedoms.
They point out that while people at all ages can be vulnerable to COVID-19, and all can spread the disease, not all people over the age of 70 are vulnerable, nor are all those under 70 resilient.
Given older adults’ multiple social roles, quarantining the more than 8.5 million people over 70 years of age will deprive society of many people who are productive and active and who can be a key part of the solution by supporting the economy, families and communities.
New funding for vaccines from government
Six coronavirus research projects, including two focused on vaccination trials, will be the first to benefit from a share of £20 million in government investment.
Two government-backed projects will receive new funding, enabling pre-clinical and clinical vaccine trials, as well as supporting researchers to develop manufacturing processes to produce a vaccine at a million-dose scale.
Other projects receiving funding examine how existing treatments could be repurposed to treat coronavirus, developing antibodies to help target the virus, and examining how people at greatest risk of catching it could be identified.
Other news round up
- The July Olympics and August Paralympics are moved to next year
- Death toll in Spain is highest yet at 514
- First death reported in Saudi Arabia
- China set to lift travel curbs on Hubei province
- Ineos is building a hand sanitiser plant to produce one million bottles a month
- YouGov poll shows 93% of Britons support the new measures announced by Boris Johnson